Prognostic value of haematological parameters and [ 18 F]FDG PET/CT metabolic parameters in head and neck cancer.

Autor: García ÁB; Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain., Infante de la Torre JR; Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain., Carbonero RB; Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain., Esteve AM; Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain., Barragan VV; Servicio de Oncología Radioterápica, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain., Vicente JS; Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain. Electronic address: justo.serrano@salud-juntaex.es., Granero PJ; Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain., Costero AU; Servicio de Medicina Nuclear, Complejo Hospitalario Universitario de Badajoz, Carretera de Portugal s/n, E-06080 Badajoz, Spain.
Jazyk: angličtina
Zdroj: Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol (Engl Ed)] 2024 Jan-Feb; Vol. 43 (1), pp. 31-38. Date of Electronic Publication: 2023 Oct 18.
DOI: 10.1016/j.remnie.2023.10.002
Abstrakt: Aim: To determine the usefulness of neutrophil/lymphocyte (N/L) and platelet/lymphocyte (P/L) ratios as well as quantitative [ 18 F]FDG PET/CT parameters as prognostic factors for overall survival (OS), cancer-specific survival (CSS) and progression-free survival (PFS) in patients with head and neck squamous cell carcinoma (HyN).
Material and Methods: Sixty-six patients (56 men) diagnosed with HyN carcinoma were retrospectively assessed over an 8-year interval. Maximum SUV (SUV max ), metabolic tumour volume (MTV) and total lesion glycolysis (TLG) parameters were determined from the PET/CT study at diagnosis. After treatment with chemoradiotherapy, patient survival was assessed. The Cox regression model and the Kaplan-Meier method were used to analyse prognostic factors and survival curves.
Results: Median follow-up was 50.4 months, with 39 recurrences-progressions and 39 deaths. In the univariate analysis, metabolic parameters, except SUV max , were predictive factors for all three survivals and the two blood parameters were predictive for OS and EFS. TLG was the only predictive factor in the multivariate analysis. The three survival curves were significantly different for the metabolic parameters and the OS curve for the N/L ratio. Correlations were seen between N/L ratio, MTV and TLG. No correlations were demonstrated between P/L ratio and metabolic parameters.
Conclusion: The use of haematological and metabolic markers would allow to identify patients with a high risk of recurrences and por survival and to individualise treatment by applying more aggressive therapies.
(Copyright © 2023 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: